Letter to the Editor
CytoSorb therapy for infective endocarditis: Expectations and a question of patient phenotype?
Terapia CytoSorb en endocarditis infecciosa: ¿expectativas y una cuestión de fenotipo de pacientes?
Nandor Marczina,b, Shahzad Rajac, Daniel Wendtd,e,
, Harriet Adamsone, Victoria Rizzof
Corresponding author
a Department of Anaesthesia and Critical Care, Harefield Hospital, London, United Kingdom
b Faculty of Medicine, Department of Surgery & Cancer, Imperial College, London, United Kingdom
c Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom
d Faculty of Medicine, University Hospital Essen, Essen, Germany
e CytoSorbents Berlin GmbH, Berlin, Germany
f Cardiothoracic Surgery, St. Thomas Hospital, Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom
